KeifeRx LLC Press Releases - EIN Presswire - Press Release Distribution Service

Published on April 14, 2026 - 17:21 GMT

KeifeRx CEO Chris Hoyt to Speak at the 2nd Annual Neuroscience Innovation Partnering & Licensing Summit in Boston

MCLEAN, VA, UNITED STATES, April 14, 2026 /⁨EINPresswire.com⁩/ -- KeifeRx, a privately held biopharmaceutical company developing oral, brain-penetrant kinase inhibitors for neurodegenerative diseases, today announced that Chief Executive Officer Chris Hoyt …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on January 5, 2026 - 15:28 GMT

KeifeRx to Present at Sachs Neuroscience Forum and Biotech Showcase During J.P. Morgan Healthcare Conference Week

KeifeRx, announced that Chief Executive Officer Chris Hoyt will be speaking at two leading investor events during J.P. Morgan Healthcare Conference week. WASHINGTON, DC, UNITED STATES, January 5, 2026 /⁨EINPresswire.com⁩/ -- KeifeRx, a biopharmaceutical …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on June 25, 2025 - 18:24 GMT

Journal of Clinical Medicine Publishes Results of Phase 2 Trial of Nilotinib in Treatment of Dementia with Lewy Bodies

Dementia with lewy bodies (“DLB”) patients, treated with 200mg of nilotinib had statistically significant improvement in cognitive function compared to placebo. MCLEAN, VA, UNITED STATES, June 25, 2025 /⁨EINPresswire.com⁩/ -- Nilotinib demonstrated a …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on June 10, 2025 - 12:32 GMT

KeifeRx Announces Expansion of Scientific Advisory Board

KeifeRx Strengthens Scientific Advisory Board with Leaders in Neurodegeneration to Support Drug Development and Strategic Partnering MCLEAN, VA, UNITED STATES, June 10, 2025 /⁨EINPresswire.com⁩/ -- KeifeRx Strengthens Scientific Advisory Board with …

Distribution channels: Banking, Finance & Investment Industry, Companies ...